IP Library Patent Application 13707259
Patent Application
App. No. 13/707,259

Use of Tetrahydropyrimidines

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/707,259
Abstract

A method of treatment of postoperative inflammatory stress and pain comprising administering a tetrahydropyrimidine selected from ectoine and/or hydroxyectoine to a patient in need of such treatment.

Claims (10)

1 . A method of treatment of postoperative inflammatory stress and pain comprising administering a tetrahydropyrimidine selected from ectoine and/or hydroxyectoine to a patient in need of such treatment.

2 . The method of claim 1 , wherein the postoperative inflammatory stress and pain is pain in the abdominal and intestinal region.

3 . The method of claim 1 , wherein the postoperative inflammatory stress and pain is pain caused by transplantation in the region of the abdomen.

4 . The method of claim 1 , wherein the postoperative inflammatory stress and pain is stress and pain after endoscopic or laparoscopic interventions caused by inflammation.

5 . The method of claim 1 , wherein the tetrahydropyrimidine is hydroxyectoine.

6 . The method of claim 1 wherein the tetrahydropyrimidine is administered to a patient in an amount of 1 to 250 mg per kg of body weight and day.

7 . The method of claim 1 wherein the tetrahydropyrimidine is in the form of a solution for topical application comprising the tetrahydropyrimidine in an amount ranging between 0.1 and 25% w/w.

8 . The method of claim 6 , wherein the tetrahydropyrimidine is administered to a patient in an amount of 5 to 150 mg per kg of body weight and day.

9 . The method of claim 6 , wherein the tetrahydropyrimidine is administered to a patient in an amount of 10 to 100 mg per kg of body weight and day.

10 . The method of claim 7 , wherein the solution comprises 9.5 to 5% w/w of the tetrahydropyrimidine.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Sep 16, 2014
From: BITOP AKTIENGESELLSCHAFT FUR BIOTECHNISCHE OPTIMIERUNG; BITOP AG
To: BITOP AG
Reel/Frame 033753/0649 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2014
From: TOLBA, RENE; VAN ECHTEN-DECKERT, GERHILD; LENTZEN, GEORG; BILSTEIN, ANDREAS
To: BITOP AKTIENGESELLSCHAFT
Reel/Frame 033323/0423 →